AskVantage

RS BioTherapeutics

RS BioTherapeutics is a startup headquartered in Cumberland, United States, founded in 2021. It has raised at least $1.1m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2021Founded
StartupStage
Cumberland, United StatesHeadquarters
HealthcareIndustry
$1.1m+Raised (SEC filings)
SeedFunding stage
Healthcare
See it on the interactive mapBook a Briefing

Funding

RS BioTherapeutics has raised at least $1.1m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

Other startups in Cumberland

Related

Questions and answers

What does RS BioTherapeutics do?

RS BioTherapeutics is classed in healthcare in its filings with the US Securities and Exchange Commission.

How much has RS BioTherapeutics raised?

At least $1.1m, according to its Form D filings with the US Securities and Exchange Commission.

Where is RS BioTherapeutics based?

RS BioTherapeutics is headquartered in Cumberland, United States.

When was RS BioTherapeutics founded?

RS BioTherapeutics was founded in 2021.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.